SSI Investment Management’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History

SSI Investment Management's BSX.PRA Position: Q2 2023 in Review

SSI Investment Management sold out of Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) in Q2 2023, closing a stake of 92,185 shares — an estimated $11.1M sold.

SSI Investment Management first reported a position in BSX.PRA in Q4 2021 and held it in 6 quarters. The position peaked at $12M in Q1 2022. 1 fund tracked by Wall St. Rank holds BSX.PRA as of Q2 2023.

• SSI Investment Management reported no remaining Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position as of Q2 2023 after selling out during the quarter.
• SSI Investment Management sold 92,185 Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A shares in Q2 2023, an estimated $11.1M.
• SSI Investment Management first reported a position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A in Q4 2021 and held it in 6 quarters.
• SSI Investment Management's Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position peaked at $12M in Q1 2022.
• 1 fund tracked by Wall St. Rank held Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A as of Q2 2023.

Based on SSI Investment Management's 13F filing for Q2 2023, filed 9 Aug 2023.